S0205 Gemcitabine w/ or w/o Cetuximab as First-Line Therapy in Locally Advanced Pancreas Cancer

NCT00075686 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

766

Enrollment

NETWORK

Sponsor class

Conditions

Pancreatic Cancer

Interventions

BIOLOGICAL: cetuximab
DRUG: gemcitabine hydrochloride

Sponsor

SWOG Cancer Research Network

Collaborators

[object Object]
[object Object]
[object Object]